Anavex Life Sciences Corp.

Anavex Life Sciences Corp.verified

AVXL

Price:

$4.45

Market Cap:

$397.60M

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the trea...[Read more]

Industry

Biotechnology

IPO Date

2006-08-02

Stock Exchange

NASDAQ

Ticker

AVXL

The Enterprise Value as of December 2025 (TTM) for Anavex Life Sciences Corp. (AVXL) is 296.44M

According to Anavex Life Sciences Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 296.44M. This represents a change of -51.31% compared to the average of 608.80M of the last 4 quarters.

Anavex Life Sciences Corp. (AVXL) Historical Enterprise Value (quarterly & annually)

How has AVXL Enterprise Value performed in the past?

The mean historical Enterprise Value of Anavex Life Sciences Corp. over the last ten years is 383.56M. The current 296.44M Enterprise Value has changed 7.63% with respect to the historical average. Over the past ten years (40 quarters), AVXL's Enterprise Value was at its highest in in the June 2021 quarter at 1.46B. The Enterprise Value was at its lowest in in the December 2018 quarter at 51.55M.

Quarterly (TTM)
Annual

Average

383.56M

Median

288.72M

Minimum

92.28M

Maximum

1.10B

Anavex Life Sciences Corp. (AVXL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Anavex Life Sciences Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 367.38%

Maximum Annual Enterprise Value = 1.10B

Minimum Annual Increase = -42.35%

Minimum Annual Enterprise Value = 92.28M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025656.50M92.01%
2024341.91M-7.99%
2023371.59M-42.35%
2022644.55M-41.45%
20211.10B367.38%
2020235.54M77.96%
2019132.36M43.43%
201892.28M-34.85%
2017141.64M19.61%
2016118.42M32.14%

Anavex Life Sciences Corp. (AVXL) Average Enterprise Value

How has AVXL Enterprise Value performed in the past?

The current Enterprise Value of Anavex Life Sciences Corp. (AVXL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

456.67M

5-year avg

623.08M

10-year avg

383.56M

Anavex Life Sciences Corp. (AVXL) Enterprise Value vs. Peers

How is AVXL’s Enterprise Value compared to its peers?

Anavex Life Sciences Corp.’s Enterprise Value is less than Erasca, Inc. (888.32M), less than MeiraGTx Holdings plc (679.86M), less than MoonLake Immunotherapeutics (724.26M), less than Arvinas, Inc. (819.49M), less than MBX Biosciences, Inc. Common Stock (803.43M), less than Astria Therapeutics, Inc. (677.40M), less than CytomX Therapeutics, Inc. (662.44M), less than Valneva SE (679.99M), less than REGENXBIO Inc. (674.74M), less than Absci Corporation (530.11M),

CompanyEnterprise ValueMarket cap
888.32M$905.04M
679.86M$692.22M
724.26M$955.18M
819.49M$911.69M
803.43M$1.03B
677.40M$748.95M
662.44M$691.03M
679.99M$742.49M
674.74M$657.04M
530.11M$560.88M

Build a custom stock screener for Anavex Life Sciences Corp. (AVXL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anavex Life Sciences Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anavex Life Sciences Corp. (AVXL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anavex Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Anavex Life Sciences Corp.'s Enterprise Value?

What is the highest Enterprise Value for Anavex Life Sciences Corp. (AVXL)?

What is the 3-year average Enterprise Value for Anavex Life Sciences Corp. (AVXL)?

What is the 5-year average Enterprise Value for Anavex Life Sciences Corp. (AVXL)?

How does the current Enterprise Value for Anavex Life Sciences Corp. (AVXL) compare to its historical average?